|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.361
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.356
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.344
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.316
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.278
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.277
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.263
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.254
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.250
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.241
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.224
|
Human |
|
|
cation transport
|
GO:0006812 |
399 |
0.219
|
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.210
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.210
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.206
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.206
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.201
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.200
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.193
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.187
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.186
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.177
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.177
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.175
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.174
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.173
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.161
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.147
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.147
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.141
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.140
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.136
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.136
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.134
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.130
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.128
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.125
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.122
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.119
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.118
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.115
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.115
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.114
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.113
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.108
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.108
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.107
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.107
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.107
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.105
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.103
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.103
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.102
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.099
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.099
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.099
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.098
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.095
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.091
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.090
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.089
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.089
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.089
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.087
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.086
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.086
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.085
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.085
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.083
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.083
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.083
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.083
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.083
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.080
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.079
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.079
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.078
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.078
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.077
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.077
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.076
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.076
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.076
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.076
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.076
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.076
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.075
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.075
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.075
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.075
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.073
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.073
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.073
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.072
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.071
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.071
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.070
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.070
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.069
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.068
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.068
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.067
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.066
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.066
|
Human |
|
|
protein secretion
|
GO:0009306 |
111 |
0.066
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.066
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.065
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.065
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.065
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.064
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.064
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.064
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.063
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.063
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.062
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.061
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.060
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.060
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.060
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.060
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.060
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.060
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.059
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.059
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.059
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.058
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.058
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.058
|
Human |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.058
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.058
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.057
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.057
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.057
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.057
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.056
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.056
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.055
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.055
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.054
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.054
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.054
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.054
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.054
|
|
|
|
negative regulation of peptide hormone secretion
|
GO:0090278 |
16 |
0.054
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.053
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.052
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.052
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.052
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.052
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.052
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.052
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.052
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.051
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.051
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.050
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.050
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.050
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.050
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.049
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.049
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.049
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.049
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.048
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.047
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.047
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.047
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.047
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.046
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.046
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.046
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.046
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.046
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.045
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.045
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.045
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.045
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.044
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.044
|
Human |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.044
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.043
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.043
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.043
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.043
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.043
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.043
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.043
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.042
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.042
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.042
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.042
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.042
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.042
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.042
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.042
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.042
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.042
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.041
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.041
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.041
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.040
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.040
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.040
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.040
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.040
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.040
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.040
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.040
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.039
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.039
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.039
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.039
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.039
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.039
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.039
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.039
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.039
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.039
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.038
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.038
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.038
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.038
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.038
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.038
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.037
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.037
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.037
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.037
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.037
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.037
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.036
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.036
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.036
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.036
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.036
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.036
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.036
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.036
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.036
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.036
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.036
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.036
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.036
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.036
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.035
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.035
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.035
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.035
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.035
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.035
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.035
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.035
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.035
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.035
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.035
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.035
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.035
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.034
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.034
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.034
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.034
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.034
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.034
|
Human |
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.034
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.034
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.034
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.034
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.034
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.033
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.033
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.033
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.033
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.032
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.032
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.032
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.032
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.032
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.032
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.032
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.032
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.032
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.032
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.031
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.031
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.031
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.031
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.031
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.031
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.031
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.031
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.031
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.031
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.031
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.031
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.031
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.031
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.030
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.030
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.030
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.030
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.030
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.030
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.030
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.030
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.030
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.030
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.029
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.029
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.029
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.029
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.029
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.029
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.029
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.029
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.029
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.029
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.029
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.029
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.029
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.029
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.029
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.029
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.029
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.029
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.028
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.028
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.028
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.028
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.028
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.028
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.028
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.028
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.028
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.028
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.028
|
Human |
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.028
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.028
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.028
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.028
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.028
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.028
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.027
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.027
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.027
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.027
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.027
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.027
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.027
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.027
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.027
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.027
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.026
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.026
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.026
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.026
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.026
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.026
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.026
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.026
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.026
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.025
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.025
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.025
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.025
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.025
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.025
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.025
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.025
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.025
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
negative regulation of mast cell degranulation
|
GO:0043305 |
4 |
0.025
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.025
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.025
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.025
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.024
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.024
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.024
|
|
|
|
negative regulation of bone trabecula formation
|
GO:1900155 |
1 |
0.024
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.024
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.024
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.024
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.024
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.023
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.023
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.023
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.023
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.023
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.023
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.023
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.023
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.023
|
Human |
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.023
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.023
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.023
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.023
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.023
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.023
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.023
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.023
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.023
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.022
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.022
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.022
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.022
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.022
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.022
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.022
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.022
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.022
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.022
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.022
|
|
|
|
negative regulation of mast cell activation
|
GO:0033004 |
6 |
0.022
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.022
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.021
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.021
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.021
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.021
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.021
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.021
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.021
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.021
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.021
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.021
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.021
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.021
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.021
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.021
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.021
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.021
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.021
|
|
